A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.
about
Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.A radiosensitivity gene signature in predicting glioma prognostic via EMT pathwayComparative transcriptome profiling of an SV40-transformed human fibroblast (MRC5CVI) and its untransformed counterpart (MRC-5) in response to UVB irradiation.Unraveling the molecular genetics of head and neck cancer through genome-wide approachesPre-exposure to ionizing radiation stimulates DNA double strand break end resection, promoting the use of homologous recombination repairThe EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells.Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient SelectionThe molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.Laser Ablation vs Open Resection for Deep-Seated Tumors: Evidence for Laser Ablation.A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy.The radiosensitivity index predicts for overall survival in glioblastomaUnderstanding the tumor microenvironment and radioresistance by combining functional imaging with global gene expression.Development of a prediction model for radiosensitivity using the expression values of genes and long non-coding RNAs.Radiosensitivity in the breast cancer management scenario: another step forward?Investigation of radiosensitivity gene signatures in cancer cell lines.Validation of a radiosensitivity molecular signature in breast cancer.Is gene expression profiling of head and neck cancers ready for the clinic?Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer.Emerging biomarkers in head and neck cancer in the era of genomics.A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.Investigational drugs for treating anal cancer and future perspectives.Radiogenomics and radiotherapy response modeling.Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?Integrating Biological Covariates into Gene Expression-Based Predictors of Radiation Sensitivity.A Raman spectroscopic study of cell response to clinical doses of ionizing radiation.Potential biomarkers for radiosensitivity in head and neck cancers.Early changes in apparent diffusion coefficients predict radiosensitivity of human nasopharyngeal carcinoma xenografts.Tumour radiosensitivity is associated with immune activation in solid tumours.A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation.Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer.Molecular biology: the key to personalised treatment in radiation oncology?Esophageal cancer 2015, more questions than answers.Bcl-xL protein: predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy.The Future of Radiobiology.MicroRNA-320 Enhances Radiosensitivity of Glioma Through Down-Regulation of Sirtuin Type 1 by Directly Targeting Forkhead Box Protein M1.Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment.The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity.Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.
P2860
Q30428813-BB3E3E3A-D7D5-4293-8378-B0F23D9F0DB0Q30820418-200217FF-6DE7-444A-A6CD-94C24701A1D1Q30919257-3067C425-49EE-4198-A298-5CEA71A3EC89Q34103984-40F8050F-850C-4742-A14B-EE156E933C83Q34982814-1479F42A-FE5C-4D24-BE79-E77093824C1CQ35025009-D9BA7CDD-13E4-4216-A416-0090D7ACD7AAQ35235233-FC16B4A8-A1AF-4D22-862A-524C1C027D5FQ35725518-A038EA6C-936D-47F9-8964-41B7B1DE8A38Q35782954-A2D5B21A-92BA-4E56-91FC-38026604ECF9Q35859128-0EA53C7A-DBFB-4A39-BC83-ED7A74A03A87Q36072599-5F03940A-9904-4D9A-B350-DCD9F905B5B2Q36344539-938C93AF-1E24-405D-AF9A-8BFA4AFEEB76Q36544110-097999FD-ADF7-4324-8AAB-E8B189A87C43Q37171084-B3E04707-1F9D-4011-9776-81C6F3DCFFB0Q37295779-2D4EF3A8-8421-484D-8EBC-88F2FBB70C5AQ37411215-B95CE006-BE3E-4D05-BC42-E6B77EBB8CE0Q37505655-47682AD4-E4F5-44DF-AECF-F2292E895C51Q37714313-0AFAD968-2C99-4605-B46D-6DD970095DB9Q37779309-BC1E1414-CB06-40CF-9E24-EFD21F1E8041Q38019396-99067601-F042-4872-80A7-E216F6B14F83Q38268896-23A6DFCB-3D87-4B32-BB99-60DB03518BDCQ38599419-C53C87E3-23D1-45F6-92E2-297FD9CFC739Q38631415-B1C5A0CD-EEAB-4359-9AA8-45258D3C6398Q38665620-6586EA69-1676-4889-B2F5-D32384EB74BAQ38687552-38CFE317-8CAF-40F9-8E5D-C23621A5CD03Q38915814-1099B8F7-D844-4AB0-9A7F-D3259B670AA1Q38920080-22550AF2-6A5A-4C81-8CD1-5195FDA2013BQ39114573-1FF6FC29-D73E-4A85-9977-DC01A94DF5C5Q39388437-A2977EE5-8C49-4DC4-8BAF-05596A10914AQ40070538-828E6943-C5F6-4A09-AE46-0E71F0E44DC1Q40676879-CF4471BD-6672-4E7D-9D47-FA75B915A10BQ42353504-50680B98-EEAA-4926-B18D-8EC1FA7BF56CQ42420913-6C4167CC-1CF2-44D0-BDE6-68A2F174D092Q43106527-A1A58A51-47C0-48B7-9C21-24FE754F7D1CQ44736357-AE64E27D-22B4-4FF4-9A4F-929B570B82AEQ46136392-6C0DADC3-CD71-4359-A815-090650960DFDQ47865792-741267C8-A5DB-40C0-9992-D7C4EC4480F6Q48214148-DCD0E121-E47A-4FEB-85DB-027A3975EE34Q48229143-CA843FFC-92E9-479F-9698-A382D177DDF0Q49885799-BD5B8AD7-E17A-4265-99E3-5191279DB8AE
P2860
A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A gene expression model of int ...... rognosis after chemoradiation.
@ast
A gene expression model of int ...... rognosis after chemoradiation.
@en
A gene expression model of int ...... rognosis after chemoradiation.
@nl
type
label
A gene expression model of int ...... rognosis after chemoradiation.
@ast
A gene expression model of int ...... rognosis after chemoradiation.
@en
A gene expression model of int ...... rognosis after chemoradiation.
@nl
prefLabel
A gene expression model of int ...... rognosis after chemoradiation.
@ast
A gene expression model of int ...... rognosis after chemoradiation.
@en
A gene expression model of int ...... rognosis after chemoradiation.
@nl
P2093
P2860
P1476
A gene expression model of int ...... rognosis after chemoradiation.
@en
P2093
Adrian C Begg
Caio Rocha-Lima
David Boulware
Douglas P Calvin
Gregory Bloom
Haiyan Zhao
Hongling Zhang
Javier F Torres-Roca
Ji-Hyun Lee
Jimmy Pramana
P2860
P304
P356
10.1016/J.IJROBP.2009.06.014
P407
P577
2009-10-01T00:00:00Z